Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:48 PM
Study NCT ID:
NCT00702494
Status:
COMPLETED
Last Update Posted:
2022-03-16
First Post:
2008-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
Sponsor:
BioInvent International AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-19
First Submit QC Date:
None
Study First Post Date:
2008-06-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-01
Last Update Post Date:
2022-03-16
Last Update Post Date Type:
ACTUAL